Don't worry, you'll have plenty of time to critique the phase 2 and phase 3 trials and the subsequent improved data. As you well know, Phase 1 was primarily to verify safety and determine dosing & best activation method. Mission accomplished, the rest is gravy.
After all of your flip flopping, wouldn't it be ironic if L is stopped early for efficacy? If it is, I expect you'll tell the world that you loaded up on out of the money calls right before it happened. You are such an investing genius!